Ensysce Biosciences (ENSCW) Minority Interest (2017 - 2025)
Ensysce Biosciences (ENSCW) reported Minority Interest of -$328970.0 for Q4 2025, little changed year-over-year from -$329458.4 in Q4 2024, and little changed quarter-over-quarter from -$328649.0 in Q3 2025.
Ensysce Biosciences (ENSCW) Minority Interest (2017 - 2025) Analysis & Trends
Ensysce Biosciences (ENSCW) has 9 years of Minority Interest data on file, last reported at -$328970.0 in Q4 2025.
- Minority Interest for Q4 2025 came in at -$328970.0, changed 0.15% year-over-year; the trailing twelve-month figure through Dec 2025 was -$328970.0 (changed 0.15% YoY), and the FY2025 annual result was -$328970.0, changed 0.15% from the prior year.
- Minority Interest was little changed at -$328970.0 in Q4 2025 per ENSCW's latest filing, from -$328649.0 in the prior quarter.
- Over five years, Minority Interest peaked at -$243653.0 in Q2 2021 and troughed at -$328970.0 in Q4 2025.
- A 5-year average of -$313746.3 and a median of -$327444.0 in 2023 frame the typical range for Minority Interest.
- The sharpest annual moves came in 2021 and 2025: Minority Interest sank 566.96% in 2021, then changed 0.0% in 2025.
- A 5-year view of Minority Interest shows it stood at -$279815.0 in 2021, then dropped by 12.65% to -$315208.0 in 2022, then slipped by 4.19% to -$328409.0 in 2023, then dropped by 0.02% to -$328483.0 in 2024, then slipped by 0.15% to -$328970.0 in 2025.
- Business Quant data shows ENSCW's Minority Interest at -$328970.0 in Q4 2025, -$328649.0 in Q3 2025, and -$328649.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Ensysce Biosciences | - | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -328,970.00 |
| Sep 30, 2025 | -328,649.00 |
| Jun 30, 2025 | -328,649.00 |
| Mar 31, 2025 | -328,483.00 |
| Dec 31, 2024 | -328,483.00 |
| Sep 30, 2024 | -328,483.00 |
| Jun 30, 2024 | -328,483.00 |
| Mar 31, 2024 | -328,483.00 |
| Dec 31, 2023 | -328,409.00 |
| Sep 30, 2023 | -327,444.00 |
| Jun 30, 2023 | -326,209.00 |
| Mar 31, 2023 | -319,149.00 |
| Dec 31, 2022 | -315,208.00 |
| Sep 30, 2022 | -327,434.00 |
| Jun 30, 2022 | -305,942.00 |
| Mar 31, 2022 | -279,633.00 |
| Dec 31, 2021 | -279,815.00 |
| Sep 30, 2021 | -279,601.00 |
| Jun 30, 2021 | -243,653.00 |
| Dec 31, 2020 | -217,625.00 |